Global and Japan Castration-Resistant Prostate Cancer (CRPC) /HRPCA Therapeutics Market Size, Status and Forecast 2020-2026

Global and Japan Castration-Resistant Prostate Cancer (CRPC) /HRPCA Therapeutics Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Oral Therapy
1.2.3 Injectable Therapy
1.3 Market by Application
1.3.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application: 2020 VS 2026
1.3.2 Hospitals & Clinics
1.3.3 Home Settings
1.3.4 Ambulatory Surgical Centers (ASCs)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Perspective (2015-2026)
2.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Growth Trends by Regions
2.2.1 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Players by Market Size
3.1.1 Global Top Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Market Share by Players (2015-2020)
3.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue
3.4 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Concentration Ratio
3.4.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue in 2019
3.5 Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Area Served
3.6 Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product Solution and Service
3.7 Date of Enter into Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Breakdown Data by Type (2015-2026)
4.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Forecasted Market Size by Type (2021-2026)
5 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Historic Market Size by Application (2015-2020)
5.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size (2015-2026)
6.2 North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2015-2020)
6.3 North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2015-2020)
6.4 North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size (2015-2026)
7.2 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2015-2020)
7.3 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2015-2020)
7.4 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size (2015-2026)
8.2 China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2015-2020)
8.3 China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2015-2020)
8.4 China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size (2015-2026)
9.2 Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2015-2020)
9.3 Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2015-2020)
9.4 Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size (2015-2026)
10.2 Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2015-2020)
10.3 Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2015-2020)
10.4 Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Astellas Inc.
11.1.1 Astellas Inc. Company Details
11.1.2 Astellas Inc. Business Overview
11.1.3 Astellas Inc. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Introduction
11.1.4 Astellas Inc. Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2015-2020))
11.1.5 Astellas Inc. Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Introduction
11.2.4 Johnson & Johnson Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2015-2020)
11.2.5 Johnson & Johnson Recent Development
11.3 Sanofi S.A
11.3.1 Sanofi S.A Company Details
11.3.2 Sanofi S.A Business Overview
11.3.3 Sanofi S.A Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Introduction
11.3.4 Sanofi S.A Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2015-2020)
11.3.5 Sanofi S.A Recent Development
11.4 Dendreon Corporation
11.4.1 Dendreon Corporation Company Details
11.4.2 Dendreon Corporation Business Overview
11.4.3 Dendreon Corporation Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Introduction
11.4.4 Dendreon Corporation Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2015-2020)
11.4.5 Dendreon Corporation Recent Development
11.5 Bayer AG
11.5.1 Bayer AG Company Details
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Introduction
11.5.4 Bayer AG Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2015-2020)
11.5.5 Bayer AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Oral Therapy
Table 4. Key Players of Injectable Therapy
Table 5. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Regions (2015-2020)
Table 9. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Regions (2021-2026)
Table 11. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Market Trends
Table 12. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Drivers
Table 13. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Challenges
Table 14. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Restraints
Table 15. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Players (2015-2020)
Table 17. Global Top Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics as of 2019)
Table 18. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 23. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Share by Type (2015-2020)
Table 24. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Market Share by Type (2021-2026)
Table 25. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Share by Application (2015-2020)
Table 26. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 27. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Share by Application (2021-2026)
Table 28. North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 29. North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Type (2015-2020)
Table 30. North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 31. North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application (2015-2020)
Table 32. North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 33. North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Country (2015-2020)
Table 34. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Type (2015-2020)
Table 36. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Country (2015-2020)
Table 40. China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 41. China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Type (2015-2020)
Table 42. China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 43. China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application (2015-2020)
Table 44. China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Region (US$ Million) (2015-2020)
Table 45. China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Region (2015-2020)
Table 46. Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Type (2015-2020)
Table 48. Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Country (2015-2020)
Table 52. Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Type (2015-2020)
Table 54. Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Country (2015-2020)
Table 58. Astellas Inc. Company Details
Table 59. Astellas Inc. Business Overview
Table 60. Astellas Inc. Product
Table 61. Astellas Inc. Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2015-2020) (US$ Million)
Table 62. Astellas Inc. Recent Development
Table 63. Johnson & Johnson Company Details
Table 64. Johnson & Johnson Business Overview
Table 65. Johnson & Johnson Product
Table 66. Johnson & Johnson Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2015-2020) (US$ Million)
Table 67. Johnson & Johnson Recent Development
Table 68. Sanofi S.A Company Details
Table 69. Sanofi S.A Business Overview
Table 70. Sanofi S.A Product
Table 71. Sanofi S.A Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2015-2020) (US$ Million)
Table 72. Sanofi S.A Recent Development
Table 73. Dendreon Corporation Company Details
Table 74. Dendreon Corporation Business Overview
Table 75. Dendreon Corporation Product
Table 76. Dendreon Corporation Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2015-2020) (US$ Million)
Table 77. Dendreon Corporation Recent Development
Table 78. Bayer AG Company Details
Table 79. Bayer AG Business Overview
Table 80. Bayer AG Product
Table 81. Bayer AG Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2015-2020) (US$ Million)
Table 82. Bayer AG Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Oral Therapy Features
Figure 3. Injectable Therapy Features
Figure 4. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Hospitals & Clinics Case Studies
Figure 6. Home Settings Case Studies
Figure 7. Ambulatory Surgical Centers (ASCs) Case Studies
Figure 8. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Report Years Considered
Figure 9. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size (US$ Million), YoY Growth 2015-2026
Figure 10. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Regions: 2020 VS 2026
Figure 11. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Regions (2021-2026)
Figure 12. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Players in 2019
Figure 13. Global Top Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue in 2019
Figure 15. North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Canada Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Germany Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. France Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. U.K. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Italy Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Russia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Nordic Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Rest of Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Asia-Pacific Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. South Korea Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. India Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Australia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Rest of Asia-Pacific Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Latin America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Mexico Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Brazil Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Turkey Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Saudi Arabia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. UAE Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Rest of Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Astellas Inc. Revenue Growth Rate in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2015-2020)
Figure 43. Johnson & Johnson Revenue Growth Rate in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2015-2020)
Figure 44. Sanofi S.A Revenue Growth Rate in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2015-2020)
Figure 45. Dendreon Corporation Revenue Growth Rate in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2015-2020)
Figure 46. Bayer AG Revenue Growth Rate in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2015-2020)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs